Test Code LABPANCS Pancreastatin, Plasma
Additional Codes
Test Name in EPIC | EPIC Test Code | Mnemonic | Mayo Test ID |
Pancreastatin | LABFPANCS | FPANP | FPANP |
Specimen Required
Patient Preparation:
1. Patient should not be on any medications that may influence Insulin levels, if possible, for at least 48 hours prior to collection.
2. Patient should be fasting 10 hours prior to collection. Patient may drink plain water; no other liquid is acceptable.
Specimen Type: Plasma
Collection Container/Tube: Z tube (MCL T701)
Submission Container/Tube: Plastic vial
Specimen Volume: 3 mL
Collection Instructions:
1. Draw 10 mL of blood in special Z-tube, pre-chilled (MCL T701).
2. Separate plasma from cells immediately after draw and freeze immediately after separation.
3. Send 3 mL of plasma frozen in a plastic vial.
Method Name
Direct Radioimmunoassay
Reporting Name
Pancreastatin, PlasmaSpecimen Type
Z-Tube PlasmaSpecimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Z-Tube Plasma | Frozen | 60 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | Reject |
Other | Specimens other than collected in Z tube (MCL T701). |
Clinical Information
Pancreastatin is a 49 amino acid peptide produced by degradation of Chromo-granin A. It inhibits Chromogranin A and Parathyroid Hormone release. Pancreastatin also inhibits release of Somatostatin upon glucose stimulation. It may also control carbohydrate metabolism and hyperglycemia. Although there are no compounds with significant structural homology with Pancreastatin, there are minor similarities to Gastrin and Anti-Diuretic Hormone. Pancreastatin reduces the early phase of Glucose induced Insulin release. Suppression of Insulin release upon Glucose stimulation is a characteristic feature of Type II Diabetes. Pancreastatin could play an important therapeutic role in the treatment of diabetes. Pancreastatin also inhibits release of Somatostatin. It may also control carbohydrate metabolism and hyperglycemia.
Reference Values
10-135 pg/mL
Performing Laboratory
Inter Science InstituteTest Classification
This radioimmunoassay was developed and its performance characteristics determined by Inter Science Institute. It has not been cleared or approved by the FDA and such approval or clearance is not required at this time. Values obtained with different methods, different laboratories or with kits cannot be used interchangeably with the results on this report. The results cannot be interpreted as absolute evidence of the presence or absence of malignant disease.CPT Code Information
83519
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
FPANP | Pancreastatin, Plasma | 49013-6 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
FPANP | Pancreastatin, Plasma | 49013-6 |
Day(s) Performed
Monday through Friday